gusperimus
Term · Oncology and biomedicine · MLC-T-ONC-014049
A derivative of the antitumor antibiotic spergualin with immunosuppressant activity. Gusperimus inhibits the interleukin-2-stimulated maturation of T cells to the S and G2/M phases and the polarization of the T cells into IFN-gamma-secreting Th1 effector T cells, resulting in the inhibition of growth of activated naive CD4 T cells; this agent may suppress growth of certain T-cell leukemia cell lines.
| Identifier | MLC-T-ONC-014049 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | DSG |
| Synonyms | deoxyspergualin; Deoxyspergualin Hydrochloride; Gusperimus Trihydrochloride |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-014049",
"term": "gusperimus",
"field": "Oncology and biomedicine",
"definition": "A derivative of the antitumor antibiotic spergualin with immunosuppressant activity. Gusperimus inhibits the interleukin-2-stimulated maturation of T cells to the S and G2/M phases and the polarization of the T cells into IFN-gamma-secreting Th1 effector T cells, resulting in the inhibition of growth of activated naive CD4 T cells; this agent may suppress growth of certain T-cell leukemia cell lines.",
"abbreviation": "DSG",
"synonyms": [
"deoxyspergualin",
"Deoxyspergualin Hydrochloride",
"Gusperimus Trihydrochloride"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/gusperimus/"
}
Record 8,233 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.